Ask A Neuroscientist: Cannabis and Grief

What’s Really Happening in Your Brain

When someone dies, the body treats it like an emergency. The brain’s alarm systems won’t shut off. Stress hormones stay elevated for weeks. Inflammation spikes. Sleep becomes impossible. This isn’t just sadness—it’s a full physiological crisis (Shear, 2015).

The delicate architecture of sleep—the normal rhythm between deep and light rest—collapses completely. Scientists call this “complicated grief” when symptoms persist beyond typical timelines, but the underlying neurobiology is remarkably consistent: the brain and body are trying to reorganize themselves around an absence that feels impossible to integrate.

This article gathers evidence to explore how cannabis might intersect with the grieving process.

The Question Around Cannabis and Grief

More bereaved individuals are turning to cannabis—not to escape their grief, but to find enough physiological stability to actually process it (Bonn-Miller et al., 2014). Some report improved sleep, while others describe a softening of anxiety that allows them to feel their emotions rather than being overwhelmed.

The question is whether science supports these experiences.

The direct answer: we don’t know yet. Research specifically examining cannabis use during bereavement doesn’t exist. What does exist is substantial evidence about how cannabis affects stress response systems, trauma processing, anxiety regulation, and memory formation—all deeply relevant to grief.

The mechanisms center on the endocannabinoid system (ECS)—a regulatory network throughout the brain and body that modulates mood, stress, memory, and pain perception. Cannabis compounds like THC (the primary intoxicating molecule) and CBD (a non-intoxicating compound with anti-anxiety properties) interact with this system in ways that research suggests could help restore balance during intense emotional disruption (Lu & Mackie, 2016; Hill et al., 2009).

What follows is not definitive answers, but an evidence-based framework for understanding how cannabis might support some individuals navigating loss.

The Grief-Stress-Cannabis Connection

When Loss Rewires the Brain

Grief fundamentally alters brain function. MRI and PET brain scans reveal heightened activity in specific regions: the amygdala (the brain’s threat-detection center) and the anterior cingulate cortex, which processes emotional pain and social loss (O’Connor et al., 2008; McConnell et al., 2018). These regions show sustained hyperactivity that correlates directly with intrusive thoughts, yearning, and intense emotional reactivity. In prolonged grief, these changes persist.

The nucleus accumbens (the brain’s primary reward center) also shows lasting alterations. This helps explain why pleasurable activities lose their appeal and why reminders of the deceased trigger such powerful responses. These aren’t temporary emotional reactions but measurable, sustained changes in brain circuitry.

The Stress System Goes Haywire

The body’s primary stress regulation system becomes dysregulated during grief. The hypothalamic-pituitary-adrenal (HPA) axis controls cortisol production—the body’s main stress hormone. During grief, cortisol levels remain elevated when they should decline, particularly in the evening, disrupting sleep and maintaining physiological hypervigilance (Fagundes et al., 2014).

These stress responses can persist for months or years, creating a dangerous cycle where emotional distress and physical illness reinforce each other. The immune system responds by releasing inflammatory signaling molecules called cytokines. Chronic emotional stress significantly elevates these markers, and research has established a bidirectional relationship: inflammation worsens mood dysregulation while emotional distress increases inflammatory responses (Slavich & Irwin, 2014).

This is one reason grief feels physically exhausting—the immune system is responding to loss as an ongoing physiological threat.

Your Body’s Built-In Cannabis System

The human body maintains an internal system designed to modulate stress and emotional responses: the endocannabinoid system. This network consists of several components working together. Cannabinoid receptors sit on cell surfaces—CB1 receptors in brain and nerve tissue, CB2 receptors in immune cells. The body also produces molecules that resemble cannabis compounds, like anandamide and 2-AG, called endogenous cannabinoids. Specialized enzymes create and break down these molecules as needed (Lu & Mackie, 2016).

Under acute stress, anandamide levels typically decrease, which correlates with increased amygdala excitability and anxiety-like responses. Meanwhile, 2-AG provides temporary buffering against stress responses. During prolonged grief, this system can become persistently dysregulated—the body’s natural stress-buffering mechanism gets depleted when it’s needed most (Hill et al., 2009).

CB1 receptors are densely concentrated in key brain regions: the amygdala, the hippocampus (the brain’s primary memory center), and the prefrontal cortex, which handles executive function—abilities like planning, decision-making, and emotional regulation. When these receptors activate, they can dampen overactivation of the HPA axis, reducing cortisol production and mitigating the long-term effects of sustained stress exposure (Hill et al., 2010; McEwen, 2007).

CB2 receptors play a different role. Predominantly found in immune cells, their activation helps regulate inflammatory responses triggered by chronic stress, potentially interrupting the inflammation-mood cycle that characterizes prolonged grief (Turcotte et al., 2016).

The ECS also modulates other neurotransmitter systems—serotonin for mood regulation, dopamine for motivation and reward processing, and GABA, the brain’s primary inhibitory neurotransmitter that slows neural activity and promotes calmness. These interactions create widespread effects across neural circuits critical for emotional well-being (Ruehle et al., 2012).

How Cannabis Interacts with Stress Systems

THC and CBD influence these pathways in distinct ways. THC partially activates CB1 receptors, which can reduce hyperactive amygdala signaling and modulate threat perception. CBD works differently—it influences serotonin receptors and indirectly enhances anandamide signaling by inhibiting the enzyme that breaks it down, producing anti-anxiety effects without intoxication (Blessing et al., 2015; De Gregorio et al., 2019).

Research from anxiety and PTSD studies suggests this pharmacological profile could potentially mitigate some of grief’s neurobiological impacts—not by eliminating the emotional experience, but by restoring enough physiological balance for individuals to process what they’re feeling rather than being overwhelmed by stress responses.

But stress regulation is only part of the picture. Grief also involves how memories are stored and accessed.

The Brain on Grief: Memory, Neuroplasticity, and Processing Loss

The Challenge of Grief-Related Memory

Grief forces the brain to continuously update its model of reality. The hippocampus and prefrontal cortex work to integrate the fact of absence into daily experience—a process involving not just cognitive understanding but the reorganization of emotional associations tied to countless environmental cues. Specific locations, sensory triggers like music or scent—all of these now carry different meanings.

Neuroplasticity (the brain’s capacity to form new connections and reorganize existing ones) is fundamental to this process. In healthy grief resolution, memories gradually lose their overwhelming emotional intensity while remaining accessible. The challenge in prolonged grief is that memories can become trapped in patterns of hyperactive emotional recall, retriggering intense distress each time they’re accessed.

Cannabis and Memory Reconsolidation

Research from trauma and anxiety studies offers relevant insights. Animal and laboratory studies conducted before human trials—preclinical research—suggest that cannabinoid signaling can promote synaptic plasticity (the strengthening or weakening of connections between neurons) and facilitate fear extinction, the process through which previously fearful associations gradually lose their capacity to trigger intense fear responses without being forgotten (Marsicano et al., 2002; Riebe et al., 2012).

Fear extinction describes how a previously fearful memory gradually loses its ability to trigger automatic fear responses while the memory itself remains intact—only the physiological reaction changes.

Studies show that CB1 receptor modulation in the amygdala and hippocampus can reduce the emotional intensity of fear-related cues in anxiety research (Das et al., 2013; Bitencourt et al., 2008). While grief and fear are distinct experiences, they share significant neurobiological overlap: both involve hyperactive amygdala responses to specific triggers and both involve difficulty updating emotional associations tied to past experiences.

CBD and Fear Extinction

CBD appears particularly relevant to these processes. Human studies demonstrate that it can enhance fear extinction and reduce hyperactive amygdala responses in individuals with anxiety disorders (Das et al., 2013). The mechanism doesn’t involve forgetting—it may help individuals access memories without triggering the same intensity of physiological stress response.

THC’s Complex Role

THC’s role in memory processing is more nuanced. At lower doses, it may reduce the emotional intensity associated with accessing stored memories, essentially modulating how distressing a memory feels without eliminating it. However, at higher doses, THC can impair both memory consolidation and retrieval, potentially interfering with the integrative processes grief requires (Hindocha et al., 2020). Dosage and cannabinoid ratios are critical considerations.

Neural Growth and Adaptation

Grief adaptation isn’t about “moving on” but rather developing a reorganized relationship to loss. Research on neuroplasticity shows that cannabis may influence proteins that promote neural growth, particularly brain-derived neurotrophic factor (BDNF), which acts like fertilizer for brain cells, supporting their survival and the formation of new connections in the hippocampus and prefrontal cortex (Fogaça et al., 2018).

Some individuals using cannabis during grief report greater openness to new experiences and improved capacity for meaning-making activities. While direct studies are lacking, this aligns with what would be expected if cannabis were facilitating adaptive neuroplastic changes— helping interrupt patterns of avoidance and withdrawal that can impede grief processing.

The endocannabinoid system’s influence on memory storage, access, and modification represents a significant mechanism through which cannabis might affect grief processing. But grief doesn’t reside solely in neural circuits—it manifests profoundly in the body as well.

The Body: Cannabis and Somatic Grief

Physical Symptoms of Loss

Grief produces distinct physical symptoms: chest constriction, muscular heaviness, breath restriction, chronic shoulder tension. These physical manifestations reflect how the nervous system’s survival structures—particularly the amygdala and brainstem—trigger protective responses that can become chronic patterns.

The body encodes grief through multiple channels: muscle tension, breathing patterns, posture, and the regulation of automatic body functions like heart rate and digestion. Bereaved individuals often unconsciously maintain body positions that reflect their emotional state—collapsed forward (protection), rigid (bracing for threat), or numb (shutdown). While cognitive approaches can help with understanding and perspective, complete emotional processing may remain elusive if the body remains locked in defensive patterns.

How Cannabis Affects Physical Stress

Cannabis interacts with these physical manifestations through multiple pathways. THC binds to CB1 receptors densely distributed in motor control regions of the brain and spinal cord, which can reduce muscle rigidity and modify proprioceptive feedback loops—the body’s internal sense of position and movement—that maintain defensive postures (Tóth et al., 2009).

CBD operates through different mechanisms. It influences serotonin receptors and enhances endocannabinoid tone by inhibiting FAAH, the enzyme that breaks down anandamide. These effects can promote parasympathetic nervous system activation—the “rest and digest” mode—which manifests as reduced heart rate, deeper breathing, and decreased muscular tension (De Gregorio et al., 2019).

Cannabis, Grief, and Body-Based Therapy

Somatic therapies—trauma-informed yoga, breathwork, somatic experiencing—focus on restoring the body’s self-regulatory capacity after loss. These approaches recognize that emotional processing requires tolerating physical sensations and maintaining bodily awareness, both of which grief often disrupts.

Combining cannabis with movement-based practices may enhance this work. THC can alter how time is perceived and how sensory information is processed, potentially allowing individuals to sustain attention on bodily sensations during therapeutic exercises (Foxe & Snyder, 2011). Balanced THC:CBD ratios paired with gentle movement practices might reduce defensive muscular bracing while providing enhanced awareness of bodily position and movement.

This combination may help establish new neural patterns through the principle that “neurons that fire together wire together”—replacing grief-associated tension with patterns oriented toward safety and present-moment experience (Hölzel et al., 2011).

Practical Considerations for Cannabis and Grief

Implementation requires careful attention to dosage and setting. Excessive THC can impair coordination or overwhelm sensory processing, undermining therapeutic goals. This work is most effective with practitioners experienced in both somatic modalities and cannabis use, typically beginning with minimal doses and emphasizing safety over intensity.

The body often holds grief-related information that exceeds what conscious awareness can access. Cannabis may help bridge this gap, but grief is also fundamentally social, and community support represents another crucial dimension of healing.

Community, Ritual, and Social Healing

Contemporary grief culture in much of the Western world tends toward isolation. Brief bereavement leave is followed by expectations of normal functioning, while social discomfort around death often leads to avoidance rather than support. The result is profound isolation during a period when humans most need connection.

Anthropological evidence shows that humans have historically grieved communally through wakes, funeral rites, and memorial gatherings. These cultural practices weren’t merely tradition—they served the function of nervous system co-regulation through collective presence. When individuals grieve together, their bodies can synchronize rhythms like heart rate and breathing. The vagus nerve, which connects the brain to major organ systems, activates states of social safety rather than remaining in threat or shutdown modes (Porges, 2011).

Cannabis in Communal Contexts

Cannabis has been used ceremonially in various cultures for centuries. When approached with intention rather than purely recreationally, sharing cannabis in community can facilitate emotional openness and vulnerability. Research indicates that cannabis may modulate amygdala reactivity and increase receptivity to positive social cues, particularly with balanced THC:CBD ratios (Duperrouzel et al., 2020).

Shared ritual around loss—incorporating elements like storytelling, memory-sharing, and mindful cannabis consumption—creates multiple therapeutic dimensions. The ritual structure provides psychological containment, the substance facilitates nervous system regulation, and the community provides interpersonal co-regulation that individual grief work cannot replicate. Oxytocin (often called the bonding hormone) increases during positive social connection, while cannabis reduces amygdala hyperreactivity and supports feelings of safety within trusted groups.

This approach isn’t about using intoxication to avoid grief but rather creating conditions where grief can be held by something larger than individual capacity.

Essential Considerations

Cannabis-supported grief work in group settings requires thoughtful facilitation. Participants must have complete autonomy to decline or participate differently, dosing should be individualized to tolerance levels, and environmental factors matter significantly—spaces must feel comfortable and emotionally safe.

Cannabis won’t be appropriate or helpful for everyone. Individual responses vary, and some people’s histories or current circumstances make cannabis use inadvisable. The goal is offering one possible framework for those who find it meaningful, not prescribing a universal approach.

When implemented thoughtfully, communal grief work incorporating cannabis can transform isolation into shared experience. The plant becomes one element within a larger therapeutic context—professional support, time, community—helping individuals carry grief without being overwhelmed by it.

Understanding these possibilities requires equally understanding the limitations and risks involved.

Cannabis as One Element Among Many in Grief

Cannabis is neither cure nor escape. Used intentionally within supportive contexts and alongside other therapeutic approaches—psychotherapy, community support, time, meaningful ritual—it may help some individuals navigate their grief journey with greater stability.

The endocannabinoid system represents a biological interface with grief processing. Cannabis, through its complex pharmacology, might help some nervous systems find balance during profound disruption—not by eliminating grief, but by expanding what becomes tolerable. Creating space for both sorrow and forward movement. For honoring loss while building what comes next.

Grief fundamentally transforms us. The question isn’t whether to grieve but how to move through it without losing essential parts of ourselves. For some people, cannabis might support that process, facilitating the neuroplastic and somatic adaptations that allow memories to remain while acute suffering gradually recedes.

The plant doesn’t hold answers, but it may help some individuals access their own capacity for healing.

About the Author

RN Collins is the staff writer at Fat Nugs Magazine, as well as 1L at Northeastern University School of Law and a neuroscientist exploring how brain health and the environment intersect. Through her writing, she bridges academic research and science communication to reframe how psychoactive plants and other traditional and alternative medicines are understood. She’s building a career that connects law, technology, and creativity—and welcomes conversations and opportunities across fields that share that vision. Connect with her on LinkedIn!

References

  • Bonn-Miller, M. O., Babson, K. A., & Vandrey, R. (2014). Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD. Drug and Alcohol Dependence, 136, 162–165.
  • Hill, M. N., Patel, S., Campolongo, P., Tasker, J. G., Wotjak, C. T., & Bains, J. S. (2009). Functional interactions between stress and the endocannabinoid system. Journal of Neuroscience, 29(41), 12573–12578.
  • Lu, H. C., & Mackie, K. (2016). An introduction to the endogenous cannabinoid system. Biological Psychiatry, 79(7), 516–525.
  • Shear, M. K. (2015). Complicated grief. New England Journal of Medicine, 372(2), 153–160.
  • Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825–836.
  • De Gregorio, D., McLaughlin, R. J., Posa, L., et al. (2019). Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain. Pain, 160(1), 136–150.
  • Fagundes, C. P., Brown, R. L., Chen, M. A., & Heijnen, C. (2014). The role of the immune system in the regulation of grief responses. Brain, Behavior, and Immunity, 36, 1–6.
  • Hill, M. N., Miller, G. E., Carrier, E. J., Gorzalka, B. B., & Hillard, C. J. (2010). Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression. Psychoneuroendocrinology, 34(8), 1257–1262.
  • McConnell, M. H., Killgore, W. D., & O’Connor, M. F. (2018). Yearning predicts subgenual anterior cingulate activity in bereaved individuals. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 3(2), 166–172.
  • McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiological Reviews, 87(3), 873–904.
  • O’Connor, M. F., Wellisch, D. K., Stanton, A. L., Eisenberger, N. I., Irwin, M. R., & Lieberman, M. D. (2008). Craving love? Enduring grief activates brain’s reward center. NeuroImage, 42(2), 969–972.
  • Ruehle, S., Rey, A. A., Remmers, F., & Lutz, B. (2012). The endocannabinoid system in anxiety, fear memory and habituation. Journal of Psychopharmacology, 26(1), 23–39.
  • Slavich, G. M., & Irwin, M. R. (2014). From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychological Bulletin, 140(3), 774–815.
  • Turcotte, C., Blanchet, M. R., Laviolette, M., & Flamand, N. (2016). The CB2 receptor and its role as a regulator of inflammation. Cellular and Molecular Life Sciences, 73(23), 4449–4470.
  • Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2008). Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. European Neuropsychopharmacology, 18(12), 849–859.
  • Das, R. K., Kamboj, S. K., Ramadas, M., et al. (2013). Cannabidiol enhances consolidation of explicit fear extinction in humans. Psychopharmacology, 226(4), 781–792.
  • Fogaça, M. V., Campos, A. C., Coelho, L. D., Duman, R. S., & Guimarães, F. S. (2018). The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system. Neuropharmacology, 135, 22–33.
  • Hindocha, C., Cousijn, J., Rall, M., & Bloomfield, M. A. P. (2020). The intersection between cannabis use, memory, and neuropsychiatry. Psychopharmacology, 237(1), 187–207.
  • Marsicano, G., Wotjak, C. T., Azad, S. C., et al. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418(6897), 530–534.
  • Riebe, C. J., Pamplona, F. A., Kamprath, K., & Wotjak, C. T. (2012). Fear relief—toward a new conceptual framework and what endocannabinoids gotta do with it. Neuroscience, 204, 159–185.
  • Foxe, J. J., & Snyder, A. C. (2011). The role of alpha-band brain oscillations as a sensory suppression mechanism during selective attention. Frontiers in Psychology, 2, 154.
  • Hölzel, B. K., Lazar, S. W., Gard, T., et al. (2011). How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspectives on Psychological Science, 6(6), 537–559.
  • Tóth, A., Blumberg, P. M., & Boczán, J. (2009). Endocannabinoids and the regulation of muscle tone. Physiology International, 96(1), 35–50.
  • Duperrouzel, J., Gruber, S. A., Sagar, K. A., Dahlgren, M. K., & Rogowska, J. (2020). The impact of cannabis use on oxytocin response to social touch. Psychopharmacology, 237(9), 2691–2700.
  • Porges, S. W. (2011). The polyvagal theory: Neurophysiological foundations of emotions, attachment, communication, and self-regulation. W. W. Norton & Company.
 

Search for Articles